Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 37,321 | 34,071 | 28,674 | 24,100 | 18,849 |
| Cost of Goods | 18,607 | 17,444 | 15,185 | 12,742 | 9,066 |
| Gross Profit | 18,714 | 16,627 | 13,489 | 11,358 | 9,783 |
| Operating Expenses | 36,531 | 39,748 | 32,255 | 37,301 | 19,455 |
| Operating Income | -17,210 | -22,677 | -18,581 | -25,201 | -9,606 |
| Interest Expense | 2,035 | 468 | 195 | 344 | 2,869 |
| Other Income | 1,508 | 3,028 | 18,168 | -12,112 | 1,552 |
| Pre-tax Income | -17,737 | -20,117 | -608 | -37,657 | -10,923 |
| Income Tax | 22 | 14 | 32 | 56 | 64 |
| Net Income Continuous | -17,759 | -20,131 | -640 | -37,713 | -10,987 |
| Net Income | $-17,759 | $-20,131 | $-640 | $-37,713 | $-10,987 |
| EPS Basic Total Ops | -3.22 | -13.02 | -0.61 | -85.60 | -9,589.60 |
| EPS Basic Continuous Ops | -3.22 | -13.02 | -0.61 | -85.63 | -9,589.35 |
| EPS Diluted Total Ops | -3.22 | -13.02 | -0.61 | -85.60 | -9,589.60 |
| EPS Diluted Continuous Ops | -3.22 | -13.02 | -0.61 | -85.63 | -9,589.35 |
| EPS Diluted Before Non-Recurring Items | -3.40 | -16.60 | -18.80 | -59.80 | N/A |
| EBITDA(a) | $-16,061 | $-21,613 | $-17,409 | $-24,661 | $-9,044 |